Reading the Tea Leaves: Anticarcinogenic Properties of (-)-Epigallocatechin-3-Gallate
Authors:
- Jennifer R. CarlsonJCJennifer R. Carlson
- Brent A. BauerBBBrent A. Bauer
- Ann VincentAVAnn Vincent
- Paul J. LimburgPLPaul J. Limburg
- Ted WilsonTWTed Wilson
- 1 June 2007
- journal article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 82 (6) , 725-732
Abstract
No abstract availableThis publication has 68 references indexed in Scilit:
- Beneficial Effects of Green Tea—A ReviewJournal of the American College of Nutrition, 2006
- Green tea extract and (−)‐epigallocatechin‐3‐gallate, the major tea catechin, exert oxidant but lack antioxidant activitiesThe FASEB Journal, 2005
- (−)-Epigallocatechin gallate causes oxidative damage to isolated and cellular DNABiochemical Pharmacology, 2003
- Antioxidant Activity of Tea Polyphenols In Vivo: Evidence from Animal StudiesThe Journal of Nutrition, 2003
- Antioxidant Effects of Tea: Evidence from Human Clinical TrialsThe Journal of Nutrition, 2003
- The Epidemiology of Tea Consumption and Colorectal Cancer IncidenceThe Journal of Nutrition, 2003
- Effect of green tea polyphenols on angiogenesis induced by an angiogenin-like proteinBiochemical and Biophysical Research Communications, 2003
- The Role of Tea in Human Health: An UpdateJournal of the American College of Nutrition, 2002
- ‘Angioprevention’: angiogenesis is a common and key target for cancer chemopreventive agentsThe FASEB Journal, 2002
- EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cellsBritish Journal of Cancer, 2001